Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-17 Acosta Andrea GVP, Chief Accouning Officer Shares withheld for taxes −285 $128.21 $37K 14,674
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +224 $67.81 $15K 103,219
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +13,810 $67.81 $936K 117,029
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion +8,977 $63.10 $566K 126,006
2020-07-13 FUCHS HENRY J President, Worldwide R&D Sale −23,011 $130.00 $3.0M 102,995
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −224 1,250
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −13,810 75,716
2020-07-13 FUCHS HENRY J President, Worldwide R&D Exercise or conversion · Stock Option (Right to buy Common Stock) −8,977 49,423
2020-07-09 BIENAIME JEAN JACQUES Chief Executive Officer Gift −425 247,533
2020-06-29 Mueller Brian EVP, Chief Financial Officer Grant or award +4,640 29,744
2020-06-29 Mueller Brian EVP, Chief Financial Officer Grant or award · Stock Option (Right to buy Common Stock) +13,230 13,230
2020-06-26 Dere Willard H Director Sale −4,430 $123.61 $548K 13,290
2020-06-19 Ajer Jeffrey Robert EVP, Chief Commercial Officer Exercise or conversion +15,000 $63.10 $947K 78,402
2020-06-19 Ajer Jeffrey Robert EVP, Chief Commercial Officer Sale −15,000 $124.00 $1.9M 63,402
2020-06-19 Ajer Jeffrey Robert EVP, Chief Commercial Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 15,700
2020-06-05 LAWLIS V BRYAN Director Sale −4,430 $107.46 $476K 18,850
2020-05-27 Slamon Dennis Director Grant or award +4,300 22,915
2020-05-27 PYOTT DAVID E I Director Grant or award +4,300 17,940
2020-05-27 MEIER RICHARD A Director Grant or award +4,300 84,340
2020-05-27 LAWLIS V BRYAN Director Grant or award +4,300 23,280

Page 35 of 36 · 707 trades